Joel Greenblatt’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.03M Buy
+20,207
New +$2.2M 0.01% 1057
2026
Q1
Sell
-16,984
Closed -$1.73M 1794
2025
Q4
$1.73M Buy
+16,984
New +$1.52M 0.01% 1086
2025
Q1
Sell
-7,821
Closed -$239K 1597
2024
Q4
$239K Sell
7,821
-7,357
-48% -$207K ﹤0.01% 1321
2024
Q3
$348K Sell
15,178
-69,570
-82% -$1.97M ﹤0.01% 1192
2024
Q2
$2.45M Buy
+84,748
New +$1.97M 0.03% 623
2023
Q4
Sell
-29,158
Closed -$864K 1372
2023
Q3
$864K Buy
29,158
+1,335
+5% +$46.9K 0.02% 825
2023
Q2
$996K Buy
+27,823
New +$799K 0.02% 769
2020
Q1
Sell
-5,400
Closed -$422K 1117
2019
Q4
$422K Buy
+5,400
New +$389K 0.01% 854
2019
Q3
Sell
-5,270
Closed -$455K 1136
2019
Q2
$455K Buy
+5,270
New +$402K 0.01% 824

Other funds holding GH

Joel Greenblatt's GH Position: Q2 2026 in Review

Joel Greenblatt opened a new position in Guardant Health (GH) in Q2 2026: 20,207 shares worth $3.03M. The stake represents 0.01% of the portfolio and ranks #1057 among its holdings. This is a return to the name: Joel Greenblatt previously reported a position in GH as recently as Q4 2025.

Joel Greenblatt first reported a position in GH in Q2 2019 and has held it in 9 quarters since. 595 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Joel Greenblatt held 20,207 shares of Guardant Health worth $3.03M as of Q2 2026.
  • Guardant Health was a new Joel Greenblatt position in Q2 2026.
  • Guardant Health made up 0.01% of Joel Greenblatt's portfolio in Q2 2026, its #1057 holding.
  • Joel Greenblatt first reported a position in Guardant Health in Q2 2019 and has held it in 9 quarters since.
  • 595 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.